BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24451080)

  • 1. Molecular profiles of non-small cell lung cancers in cigarette smoking and never-smoking patients.
    Szymanowska-Narloch A; Jassem E; Skrzypski M; Muley T; Meister M; Dienemann H; Taron M; Rosell R; Rzepko R; Jarząb M; Marjański T; Pawłowski R; Rzyman W; Jassem J
    Adv Med Sci; 2013; 58(2):196-206. PubMed ID: 24451080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
    J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XPC mRNA level may predict relapse in never-smokers with non-small cell lung cancers.
    Yeh KT; Wu YH; Lee MC; Wang L; Li CT; Chen CY; Lee H
    Ann Surg Oncol; 2012 Mar; 19(3):734-42. PubMed ID: 21861227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinicopathological and survival differences between never and ever smokers with non-small cell lung cancer.
    Muallaoglu S; Karadeniz C; Mertsoylu H; Ayberk Besen A; Sezer A; Murat Sedef A; Kose F; Ozyilkan O
    J BUON; 2014; 19(2):453-8. PubMed ID: 24965406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.
    Tseng JE; Kemp BL; Khuri FR; Kurie JM; Lee JS; Zhou X; Liu D; Hong WK; Mao L
    Cancer Res; 1999 Oct; 59(19):4798-803. PubMed ID: 10519387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AKR1B10 is associated with smoking and smoking-related non-small-cell lung cancer.
    Kang MW; Lee ES; Yoon SY; Jo J; Lee J; Kim HK; Choi YS; Kim K; Shim YM; Kim J; Kim H
    J Int Med Res; 2011; 39(1):78-85. PubMed ID: 21672310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
    Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
    Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
    Grepmeier U; Dietmaier W; Merk J; Wild PJ; Obermann EC; Pfeifer M; Hofstaedter F; Hartmann A; Woenckhaus M
    Int J Oncol; 2005 Aug; 27(2):481-8. PubMed ID: 16010431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.
    Bryant A; Cerfolio RJ
    Chest; 2007 Jul; 132(1):185-92. PubMed ID: 17573517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.
    Hayashi M; Tokuchi Y; Hashimoto T; Hayashi S; Nishida K; Ishikawa Y; Nakagawa K; Tsuchiya S; Okumura S; Tsuchiya E
    Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.
    Hastürk S; Kemp B; Kalapurakal SK; Kurie JM; Hong WK; Lee JS
    Cancer; 2002 Feb; 94(4):1023-31. PubMed ID: 11920472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers.
    Sanchez-Cespedes M; Decker PA; Doffek KM; Esteller M; Westra WH; Alawi EA; Herman JG; Demeure MJ; Sidransky D; Ahrendt SA
    Cancer Res; 2001 Mar; 61(5):2092-6. PubMed ID: 11280771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer.
    Nakano J; Huang CL; Liu D; Ueno M; Sumitomo S; Yokomise H
    Int J Oncol; 2005 Nov; 27(5):1215-21. PubMed ID: 16211215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic inactivation of retinoid X receptor genes in non-small cell lung cancer and the relationship with clinicopathologic features.
    Lee SM; Lee JY; Choi JE; Lee SY; Park JY; Kim DS
    Cancer Genet Cytogenet; 2010 Feb; 197(1):39-45. PubMed ID: 20113835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.
    Mounawar M; Mukeria A; Le Calvez F; Hung RJ; Renard H; Cortot A; Bollart C; Zaridze D; Brennan P; Boffetta P; Brambilla E; Hainaut P
    Cancer Res; 2007 Jun; 67(12):5667-72. PubMed ID: 17575133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas.
    Fukumoto S; Yamauchi N; Moriguchi H; Hippo Y; Watanabe A; Shibahara J; Taniguchi H; Ishikawa S; Ito H; Yamamoto S; Iwanari H; Hironaka M; Ishikawa Y; Niki T; Sohara Y; Kodama T; Nishimura M; Fukayama M; Dosaka-Akita H; Aburatani H
    Clin Cancer Res; 2005 Mar; 11(5):1776-85. PubMed ID: 15755999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma.
    Kikuchi S; Yamada D; Fukami T; Maruyama T; Ito A; Asamura H; Matsuno Y; Onizuka M; Murakami Y
    Cancer; 2006 Apr; 106(8):1751-8. PubMed ID: 16534787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
    Ishikawa M; Miyahara R; Sonobe M; Horiuchi M; Mennju T; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Huang CL; Date H
    Lung Cancer; 2012 Jun; 76(3):431-8. PubMed ID: 22236865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis.
    Boyle JM; Tandberg DJ; Chino JP; D'Amico TA; Ready NE; Kelsey CR
    Cancer; 2015 Feb; 121(4):598-604. PubMed ID: 25283893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.